Fifth Third Bancorp’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.11K Hold
1,280
﹤0.01% 4024
2026
Q1
$3.03K Buy
+1,280
New +$4.43K ﹤0.01% 3963
2022
Q4
Sell
-619
Closed -$2K 2730
2022
Q3
$2K Buy
+619
New +$2.8K ﹤0.01% 2454
2022
Q2
Sell
-484
Closed -$4K 2751
2022
Q1
$4K Buy
+484
New +$3.75K ﹤0.01% 2388
2021
Q4
Sell
-133
Closed -$2K 2761
2021
Q3
$2K Buy
+133
New +$2.06K ﹤0.01% 2484

Other funds holding ORGO

Fifth Third Bancorp's ORGO Position: Q2 2026 in Review

Fifth Third Bancorp held its Organogenesis Holdings (ORGO) position steady in Q2 2026 at 1,280 shares worth $3.11K. The position accounts for ﹤0.01% of the portfolio, ranked #4024.

Fifth Third Bancorp first reported a position in ORGO in Q3 2021 and has held it in 5 quarters since. The position peaked at $4K in Q1 2022. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Fifth Third Bancorp held 1,280 shares of Organogenesis Holdings worth $3.11K as of Q2 2026.
  • Fifth Third Bancorp left its Organogenesis Holdings share count unchanged in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4024 holding.
  • Fifth Third Bancorp first reported a position in Organogenesis Holdings in Q3 2021 and has held it in 5 quarters since.
  • Fifth Third Bancorp's Organogenesis Holdings position peaked at $4K in Q1 2022.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.